To make sure that the results of the OPUS clinical study are accurate and can be compared with other SLE clinical studies around the world, everyone who participates must meet certain safety and health requirements, called ‘eligibility criteria’. These eligibility criteria help researchers make sure that everyone in the clinical study is similar in certain important ways. This similarity allows the researchers to clearly see how the investigational drug affects people around the world.
Have a confirmed diagnosis of SLE and be currently experiencing symptoms of the disease
Be aged 18 years or older
Be prepared to keep taking their current SLE treatment together with the investigational drug or placebo
Must not be pregnant or planning to be pregnant for the duration of the clinical study
The medical team at the clinic or hospital will ask you questions about your health and any medications you are taking, and perform some tests to see whether you are eligible for the OPUS clinical study.
Please note that all study-related visits, tests, and investigational drug are provided at no cost. In addition, reimbursement for study-related travel and time may be provided to people who qualify, depending on country-specific law.
You can ask your medical team about the possibility of reimbursement for study-related travel and time when you enroll in the OPUS clinical study.
Philippines 
日本語 